Showing 6,049 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Diabetes

Protease inhibitor therapy increases underlying genetic risk of diabetes for women with HIV

News
1 July 2014
New & experimental HIV treatments

Triumeq® (dolutegravir/abacavir/lamivudine) single-tablet regimen receives positive CHMP opinion in Europe for the treatment of HIV

Editor's pick
Viiv Healthcare press release
30 June 2014
Bad science & bogus treatments

Researcher Admits to HIV Vaccine Fraud

Editor's pick
Guardian Liberty Voice
26 June 2014
Side effects

Lowering toxicity of new HIV drugs predicted to improve life expectancy

Editor's pick
EurekAlert
26 June 2014
Cancer

Advice on Best ART Regimen for Patients Taking Cancer Therapy

Editor's pick
International AIDS Society
25 June 2014
Treatment outcomes & life expectancy

Mortality with HIV drops sharply in Georgia after 2004 cART rollout

Editor's pick
International AIDS Society
23 June 2014
Treatment guidelines

Dolutegravir in HIV-1 infection: Added benefit in adult patients

Editor's pick
Science Daily
19 June 2014
New & experimental HIV treatments

Glaxo's ViiV Joins J&J's Janssen to Develop Single-Pill HIV Drug

Editor's pick
Bloomberg
13 June 2014
TB transmission & prevention

South Africa: Antiretrovirals Credited for TB Decline

Editor's pick
Health-e
13 June 2014
PrEP science

PrEP users say it provides an 'extra layer of protection' and 'peace of mind'

News
12 June 2014
How HIV works

Paper explores new theory on spread of HIV by "popular" cells

Editor's pick
HIV / AIDS News From Medical News Today
11 June 2014
Changing treatment

People starting therapy on a boosted protease inhibitor don't need to switch after one virological failure episode, study indicates

News
9 June 2014
New & experimental HIV treatments

First Patient Enrolled in New Phase 3 Trial Program Investigating a Once-Daily formulation of raltegravir (Isentress)

Editor's pick
Merck
6 June 2014
Ageing & HIV

AAHIVM, AGS, and ACRIA release updated recommendations for older patients with HIV

Editor's pick
EATG
6 June 2014
Treatment for women

Marriage a Barrier to ARV treatment for Swazi Women (part two of a series on Option B+)

Editor's pick
IPS
5 June 2014
Starting treatment

Five-drug ART has no advantage over three drugs for early HIV

Editor's pick
International AIDS Society
4 June 2014
TB treatment

An activist's guide to TB drugs

Editor's pick
TAG
4 June 2014
UK health services

‘Appalling service’ provided by Healthcare at Home leaves patients without drugs

Editor's pick
Bureau of Investigative Journalism
3 June 2014
Health monitoring in resource-limited settings

Study shows prognostic value of viral load monitoring among people living with subtype C HIV in South Africa

News
2 June 2014
TB treatment

In HIV/TB coinfection, raltegravir may be an alternative to efavirenz

Editor's pick
Medscape
2 June 2014
Improving HIV care

Divided Opinions on Feasibility of Kenya’s Option B+ Roll Out

Editor's pick
Inter Press Service
29 May 2014
New & experimental hepatitis C treatment

No critical interactions between ledipasvirsofosbuvir and certain key antiretrovirals

Editor's pick
NATAP
29 May 2014
Drug interactions & pharmacokinetics

Calcium and Iron Supplements Lower Dolutegravir Levels When Taken Between Meals

Editor's pick
NATAP
24 May 2014
New & experimental HIV treatments

Dolutegravir in HIV-1 infection: added benefit in adult patients

Editor's pick
IQWIG
23 May 2014